This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

BOC Sciences

Profile

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification and characterization. We master preclinical drug development and technology platforms to lay the necessary foundation for industrialization. Our technology platforms include mucosal vaccine technology platform, research animals & models platform, protein technology platform, antibody technology platform, cell technology platform, molecular related technology platform and small molecule drug platform.
Our XDC platform contains many featured services such as antibody-drug conjugates, antibody-oligonucleotide conjugates, small molecule-drug conjugates, peptide-oligonucleotide conjugates, nanobody conjugate and so on. In addition to these services, we also provide some XDC products including PEG derivatives, lipids, bio-conjugations and adjuvants.We can do animal studies, In vivo PK/PD, ADME and CRISPR/Cas9-based services as well.
As the largest manufacturer of pseudoUridine and N1-methylpseudoUridine in the world, we supply hundreds of nucleosides, nucleotides, phosphoramidites, amino acid derivatives and peptides. We have cGMP capability to meet pharmaceutical needs.